BOVA Global Logo
BOVA Global Logo
global icon
Change region
Order
Change region
Research Paper

Pharmacokinetics and Bioequivalance of Five Commercially Available Formulations of Omeprazole: A Preliminary Report.

Sykes, B. W., C. Underwood and P. C. Mills (2014). “Pharmacokinetics and Bioequivalance of Five Commercially Available Formulations of Omeprazole: A Preliminary Report.” Equine Veterinary Journal46(S47): 22-22.

Pharmacokinetics and Bioequivalance of Five Commercially Available Formulations of Omeprazole: A Preliminary Report – Sykes – 2014 – Equine Veterinary Journal – Wiley Online Library

Related

Managing Equine Gastric Disease - Part 2

Clinical approach to the EGGD case (2026)

Blogs July 21, 2026 Equine Gastric Disease
A practical veterinary guide to diagnosing and managing equine glandular gastric disease, including…
Read More
Gastric Disease Evolving Insights-Bova Aus Equine Roadshow 2026

Gastric Disease: Evolving Insights, Individualised Care | Bova Aus Equine Roadshow 2026

Webinars April 15, 2026 Equine Gastric Disease,Equine Roadshow
Originally developed for the Bova and Virbac Equine Roadshow 2026, in Australia, this session sees…
Read More
Equine Gastric Disease The ins and outs

Equine Gastric Disease The ins and outs

Useful Resources February 23, 2024 Equine Gastric Disease
Discover the ins and outs of Equine Gastric Disease, a common condition affecting horses. ​Learn…
Read More
Load More
Date:
June 24, 2023
Author:Yutong Gang
Tags:

You May Also Like

Short Treatment of 42 Days with Oral GS-441524 Results in Equal Efficacy as the Recommended 84-Day Treatment in Cats Suffering from Feline Infectious Peritonitis with Effusion-A Prospective Randomized Controlled Study
June 23, 2023
Short Treatment of 42 Days with Oral GS-441524 Results in Equal Efficacy as the Recommended 84-Day Treatment in Cats Suffering from Feline Infectious Peritonitis with Effusion-A Prospective Randomized Controlled Study
Retrospective study and outcome of 307 cats with feline infectious peritonitis treated with legally sourced veterinary compounded preparations of remdesivir and GS-441524 (2020-2022).
June 23, 2023
Retrospective study and outcome of 307 cats with feline infectious peritonitis treated with legally sourced veterinary compounded preparations of remdesivir and GS-441524 (2020-2022).